Brii Bio receives an “A” grade in the latest MSCI ESG Rating DURHAM, N.C. and BEIJING, April 27, 2023 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company,” stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.